← Scroll for more →
Financial Statements — EPOW
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 21.84 | 19.92 | 1.26 | 15.24 | 1.40 | 5.81 | 1.66 | 22.05 | 13.92 |
| Short-term Investments | 0.09 | -- | -- | -- | -- | 3.28 | 3.34 | 4.61 | 5.96 |
| Accounts Receivable | 9.94 | 23.31 | 28.99 | 12.68 | 8.94 | 13.47 | 200.00 | 1.99 | 6.86 |
| Inventory | 24.11 | 30.34 | 17.66 | 25.27 | 15.84 | 2.90 | 12.24 | 11.43 | 3.11 |
| Total Current Assets | 72.24 | 90.72 | 63.01 | 61.08 | 35.82 | 52.88 | 44.64 | 49.25 | 34.35 |
| Property, Plant & Equipment | 63.95 | 62.83 | 60.50 | 62.15 | 65.56 | 40.82 | 41.47 | 4.83 | 3.35 |
| Intangible Assets | 0.22 | 0.07 | 0.07 | 0.08 | 0.08 | 3.46 | 3.96 | 14.26 | 3.59 |
| Total Non-current Assets | 84.19 | 84.68 | 80.01 | 80.48 | 84.69 | 68.58 | 62.38 | 51.71 | 24.35 |
| Total Assets | 156.44 | 175.40 | 143.02 | 141.56 | 120.50 | 121.46 | 107.02 | 100.96 | 58.70 |
| Accounts Payable | 36.81 | 39.24 | 49.96 | 44.34 | 33.87 | 19.12 | 12.26 | 5.31 | 0.03 |
| Short-term Debt | 5.86 | 5.72 | 2.92 | 2.75 | 7.04 | 50.00 | -- | -- | -- |
| Total Current Liabilities | 100.67 | 109.42 | 86.76 | 70.58 | 63.49 | 40.58 | 26.02 | 11.89 | 1.72 |
| Long-term Debt | 39.56 | 38.87 | 26.41 | -- | 3.51 | 0.64 | 3.02 | -- | -- |
| Total Non-current Liabilities* | 39.88 | 40.71 | 28.97 | 32.03 | 11.68 | 14.29 | 7.64 | 0.00 | 0.00 |
| Total Liabilities | 140.54 | 150.12 | 115.73 | 102.61 | 75.17 | 54.88 | 33.66 | 11.89 | 1.72 |
| Retained Earnings | (58.88) | (43.50) | (42.24) | (34.92) | (30.47) | (10.94) | (6.23) | 9.71 | 17.26 |
| Total Stockholder Equity | (12.10) | (10.96) | (10.26) | (2.75) | 2.65 | 23.20 | 28.68 | 44.38 | 53.85 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Total Revenue | 27.97 | 22.28 | 20.71 | 9.95 |
| Cost of Revenue | 24.27 | 1.98 | 19.50 | 8.62 |
| Gross Profit | 3.70 | 0.02 | 0.62 | 3.39 |
| Research & Development | 0.75 | 0.85 | 0.75 | 0.10 |
| Selling, General & Admin | 3.12 | 4.21 | 4.58 | 5.47 |
| Total Operating Expenses | 4.37 | 5.42 | 6.05 | 15.40 |
| Operating Income | (0.67) | (5.40) | (5.43) | (5.14) |
| Interest Expense | 0.37 | -- | 0.14 | -- |
| Pretax Income | (2.84) | (6.02) | (5.83) | -- |
| Tax Provision | 0.00 | 0.02 | 0.00 | 1.01 |
| Net Income | (1.26) | (4.45) | (4.71) | (7.52) |
| Basic EPS | (0.05) | (0.21) | (0.21) | (0.31) |
| Diluted EPS | (0.05) | (0.21) | (0.21) | (0.31) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Operating Cash Flow | (19.88) | (6.95) | (4.29) | (3.60) |
| Capital Expenditures | 5.00 | 0.98 | 2.29 | 2.04 |
| Free Cash Flow* | (24.88) | (7.93) | (6.58) | (5.64) |
| Investing Cash Flow | (9.33) | 2.05 | (3.98) | (26.33) |
| Financing Cash Flow | 46.86 | 18.07 | 10.96 | 37.81 |
← Scroll for more columns →
* Derived from reported values